Sherman v. Callahan

CourtCourt of Appeals for the Tenth Circuit
DecidedApril 8, 1998
Docket97-7085
StatusUnpublished

This text of Sherman v. Callahan (Sherman v. Callahan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sherman v. Callahan, (10th Cir. 1998).

Opinion

F I L E D United States Court of Appeals Tenth Circuit UNITED STATES COURT OF APPEALS APR 8 1998 FOR THE TENTH CIRCUIT PATRICK FISHER Clerk

FRANCES SHERMAN,

Plaintiff-Appellant,

v. No. 97-7085 (D.C. No. 96-CV-217) KENNETH S. APFEL, Commissioner, (E.D. Okla.) Social Security Administration, *

Defendant-Appellee.

ORDER AND JUDGMENT **

Before ANDERSON, McKAY, and LUCERO, Circuit Judges.

Plaintiff appeals from a district court order affirming the Commissioner’s

decision to deny her applications for disability insurance benefits and

supplemental security income. 1 In what became the final decision of the

* Pursuant to Fed. R. App. P. 43(c), Kenneth S. Apfel is substituted for John J. Callahan, former Acting Commissioner of Social Security, as the defendant in this action. ** This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3. 1 After examining the briefs and appellate record, this panel has determined (continued...) Commissioner, the administrative law judge (ALJ) found that plaintiff’s chronic

hepatitis C, depression, and substance addiction constituted severe impairments.

The ALJ further found, however, that plaintiff’s impairments only restricted her

to light work involving simple tasks. Therefore, the ALJ concluded that plaintiff

retained the residual functional capacity (RFC) to perform four of her past jobs,

which involved light or sedentary, unskilled work.

We review the Commissioner’s decision to determine whether it “is

supported by substantial evidence and adheres to applicable legal standards.”

Berna v. Chater, 101 F.3d 631, 632 (10th Cir. 1996). “Because [s]ubstantiality of

evidence must be based upon the record taken as a whole, we must meticulously

examine the record to determine whether the evidence in support of the

[Commissioner’s] decision is substantial and take into account whatever in the

record fairly detracts from its weight.” Washington v. Shalala, 37 F.3d 1437,

1439 (10th Cir. 1994) (quotations and citations omitted). We reverse and remand

for further proceedings in light of cumulative errors undermining the ALJ’s

analysis of plaintiff’s impairments.

1 (...continued) unanimously to grant the parties’ request for a decision on the briefs without oral argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1.9. The case is therefore ordered submitted without oral argument.

-2- I. The Evidence

In June 1991, plaintiff began seeking treatment from Dr. Pena, a family

practitioner, for headaches, fatigue, and depression. In September 1992, blood

tests established that plaintiff, an admitted intravenous drug user, had hepatitis.

She later started having abdominal pain and diarrhea, for which she also sought

treatment, and ultimately stopped working in December 1992. Plaintiff said that

she had been falling asleep at work for days before she left.

In January 1993, plaintiff was still complaining of fatigue and Dr. Pena

referred her to Dr. Burdick, a gastroenterologist, who had a long discussion with

her about the potential for treatment with Interferon. 2 Dr. Burdick reported that

plaintiff’s chronic fatigue was probably secondary to her hepatitis, noting that

“fatigue does not differentiate between patients with mild or severe liver disease.”

Appellant’s App., Vol. II, at 197.

After plaintiff’s longtime boyfriend died of hepatitis in March 1993, she

became even more depressed. Plaintiff moved to California, where she slipped

back into using drugs. She continued to suffer occasional bouts of diarrhea,

frequent headaches, fatigue, and peripheral swelling, and sought treatment from

2 Interferon is an antiviral agent used in the treatment of certain kinds of hepatitis. It is “given by . . . injection, is expensive, and produces bothersome flu-like side effects in almost all patients.” The Merck Manual of Diagnosis & Therapy 906 (Robert Berkow & Andrew J. Fletcher eds., 16th ed. 1992).

-3- Dr. Allen, an internist. Dr. Allen referred plaintiff to Dr. Olson, a

gastroenterologist, who performed a liver biopsy. The biopsy established that

plaintiff had chronic active hepatitis C, 3 and Dr. Olson recommended treatment

with Interferon. Because depression can be a side effect of Interferon, Dr. Olson

advised that the treatment be delayed three months, to see if plaintiff’s depression

resolved. In August 1993, Dr. Allen wrote a letter to the Social Security

Administration discussing Dr. Olson’s intention of beginning Interferon treatment

once plaintiff’s depression resolved. Dr. Allen stated that he believed plaintiff

was presently disabled, but that her future course might improve--presumably

with Interferon treatment--to the point that she would no longer be disabled.

In July 1993, plaintiff saw Dr. Kerwin for a second opinion. Plaintiff

complained of fatigue, forgetfulness, blackouts, and swelling. Dr. Kerwin noted

that most of plaintiff’s symptoms were related to her hepatitis and depression.

Plaintiff saw Dr. Kerwin numerous times over the next eight months, complaining

of fatigue and depression, for which she was prescribed antidepressants and

3 Chronic active hepatitis, sometimes called chronic aggressive hepatitis is a “serious disorder [which] often results in liver failure and/or cirrhosis. . . . Nonspecific malaise, anorexia, and fatigue often dominate the clinical picture, sometimes with low-grade fever and nondescript upper abdominal discomfort. Jaundice is variable and is not always present.” The Merck Manual of Diagnosis & Therapy, at 905. “Prognosis is highly variable. . . . Cases associated with [hepatitis B virus] or [hepatitis C virus] tend to progress and . . . are usually resistant to therapy.” Id. at 906.

-4- antianxiety medication. In November 1993, Dr. Kerwin filled out a form for

plaintiff’s lender on which he stated that plaintiff had been temporarily totally

disabled since December 1992, and that her anticipated recovery date was

“indefinite.” Id. at 281.

At the beginning of May 1994, plaintiff moved to Oklahoma so that she

could be treated at the Choctaw Nation Hospital. Plaintiff was first seen there on

May 3 and was still being treated there at the time of the hearing before the ALJ

in December 1994. Liver tests performed in May and June 1994 showed an

upward trend in certain liver enzymes, and hospital records showed continued

complaints of headaches, diarrhea, abdominal pain, decreased energy, depression

and anxiety. Plaintiff was prescribed antidepressants and antianxiety medications,

but was advised to avoid Tylenol and other medications that are detoxified by the

liver. At her request, plaintiff also was referred to Dr. Golla, a gastroenterologist.

Although plaintiff testified at the administrative hearing that Dr. Golla was

treating her, the record does not contain any of his treatment notes or other

medical records.

On December 14, 1994, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Sherman v. Callahan, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sherman-v-callahan-ca10-1998.